TSXV:NDVA.H - Post by User
Post by
LongTheGreenson Jul 04, 2018 8:25am
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
173 Views
Post# 28266029
Indiva: best relative value in the sector
Indiva: best relative value in the sector These bashers come here either with short positions or having bought too early and taken a nasty loss.
The MC is under 60 million and these guys are awesomely positioned for the rec market. They will offer top shelf cannabis and sell most of it to the medical market until they scale up, which is more profitable and great to see from the company. The medical/pharma market will be worth way more one day.
From a marketing perspective, selling under the Bhang flag can only benefit them. The brand has a cult follwing worldldwide and Bhang has recently announced going public in Canada at a higher valuation than Indiva paid for the 5% and 50/50 JV. Bhang is the real deal and will be great to piggyback off of considering the tight branding restrictions..
Indiva offers great upside/downside numbers and I expect the market cap to reach 150 million by year end on the conservative side and well north of 200 million when the ramp up on edibles and derivitives picks up in preparation for those legislative changes in 2019.
Sell me your shares, bashers.